Improving diagnostic tests for Hepatitis B
Official title: RADx Innovation Funnel for Hepatitis B Diagnostics – Commercialization Center
Funded at Venturewell · NIH-11205626 · Data updated 2026-11-12
This study is working to make better and faster tests for Hepatitis B, so patients can get diagnosed more easily and quickly, improving their overall healthcare experience.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Venturewell NIH-funded |
| Lab location | 1 site (Hadley, United States) |
| Project start | September 30, 2024 |
| Project end | September 29, 2026 |
| Funding year | 2024 |
| Award (this year) | $400,000 |
| NIH project number | 75N92022D00013-0-759202400004-1 |
| Project ID | NIH-11205626 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk for Hepatitis B or those who may require testing for the virus.
✕Less likely to help
Patients who are not at risk for Hepatitis B or who have already been diagnosed and are receiving treatment may not benefit from this research.
What this research studies
This research aims to enhance the availability of accurate and reliable diagnostic tests for Hepatitis B by accelerating their regulatory review process. The project will leverage technical and clinical expertise to support the development and commercialization of innovative point-of-care diagnostic technologies. Patients can expect advancements in testing that could lead to quicker and more accessible diagnosis of Hepatitis B, ultimately improving their healthcare experience.
Why it matters
Potential benefit: If successful, this research could provide patients with faster and more accurate Hepatitis B diagnostic tests.
How similar studies have gone: Other research initiatives focused on rapid diagnostic technologies have shown promise, indicating that this approach could lead to significant advancements in Hepatitis B testing.
Where this research is happening
-
Venturewell
Hadley, United States Active
Researchers
- Principal investigator: Marino, Mark — Venturewell
- Study coordinator: Marino, Mark
Related research
Other NIH-funded projects on the same topics.
-
HBV cure clues in people with and without HIV
This project studies how HBV-specific B and T cell responses relate to curing hepatitis B in people with and without HIV.
-
HBV cure factors in people with and without HIV
This project studies how HBV-specific immune cells behave during treatment and whether people with HIV respond differently than those without HIV.
-
HBV prevention in community pharmacies: a first step in a low-resource setting
This pilot project tests whether hepatitis B screening and vaccination can be integrated into everyday community pharmacy services to reach more people.
-
Blood markers to catch early liver cancer in Hispanic people with hepatitis B
This project will see if a blood test can find liver cancer earlier in Hispanic people who have chronic hepatitis B.
-
Early blood markers to find hepatitis B–related liver cancer in Hispanics
This project will use immune-related blood markers to find liver cancer earlier in people with chronic hepatitis B, focusing on Hispanic adults.
-
HBV safety with long-acting HIV therapy for people with HIV
A study to understand how long-acting HIV meds affect hepatitis B in people living with HIV and how to best monitor and protect them.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.